Clinical Trials Directory

Trials / Completed

CompletedNCT00057642

Improving Retention of Hispanics Receiving Antidepressant Therapy

Improving Hispanic Retention in Antidepressant Therapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
New York State Psychiatric Institute · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study will develop an intervention that will increase the retention of Hispanics with major depression in antidepressant therapy.

Detailed description

Despite major advances in the treatment of psychiatric disorders, Hispanics continue to underutilize mental health services relative to their own mental health needs. Cultural factors are important causes of underutilization. To date, however, attempts to boost utilization by improving the cultural congruence of psychiatric services have not focused on retaining Hispanics in antidepressant therapy. Motivational Interviewing (MI) is a time-limited psychotherapy that has successfully improved treatment retention among patients with dually diagnosed substance abuse and psychiatric disorders. During Phase I of this study, MI is adapted for use as an adjunctive therapy with antidepressant treatment and culturally adapted to Hispanic participants. In Phase II, participants receive sertraline for 12 weeks and participate in four sessions of MI therapy as a supplementary intervention designed to encourage treatment retention. Participants who are intolerant to sertraline or have an inadequate response by Week 6 are switched to venlafaxine ER while continuing to receive MI and to complete study assessments. A follow-up interview is conducted 6 months after the termination of treatment.

Conditions

Interventions

TypeNameDescription
DRUGSertraline
DRUGVenlafaxine Extended Release

Timeline

Start date
2002-09-01
Primary completion
2006-08-01
Completion
2006-08-01
First posted
2003-04-07
Last updated
2013-08-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00057642. Inclusion in this directory is not an endorsement.